• About us
    • About Lindahl
    • How we work
    • Said about Lindahl
    • Press
    • Find us
    • Privacy
  • Areas
    • Commercial dispute resolution
    • IT/Tech
    • Intellectual property
    • Life Sciences
    • M&A
    • All areas
  • Our people
    • Stockholm
    • Göteborg
    • Malmö
    • Uppsala
    • Helsingborg
    • Örebro
  • Latest news
    • Cases and transactions
    • News
    • Events
    • Knowledge
    • Portraits
  • Offices
    • Stockholm
    • Göteborg
    • Malmö
    • Uppsala
    • Örebro
    • Helsingborg

Lindahl advises Nanologica AB (publ) in connection with rights issue

  • Home
  • Latest news
  • Cases and transactions
  • 2022
  • Lindahl advises Nanologica AB (publ) in connection with rights issue

Lindahl acted as legal counsel when Nanologica recently carried out a rights issue, which was resolved by the board of directors on August 23, 2022, and approved by the extraordinary general meeting on September 15, 2022. The subscription period ended in October 2022 and the outcome shows that the rights issue was subscribed for up to 85 percent, of which Flerie Invest AB subscribed for 36.6 percent in accordance with an underwriting commitment. Nanologica will thus receive approximately MSEK 79.8 before issue costs.

The purpose of the rights issue is to finance intensified efforts and investments in the preparative chromatography business area in order to strengthen the company’s competitiveness and take advantage of the favorable market conditions.

Nanologica’s share is listed on Nasdaq Stockholm Main Market and the company manufactures, develops, and sells nanoporous silica particles for applications within life science. Nanologica is world-leading in controlling the shape, size, porosity, and surface properties of silica particles, creating opportunities to develop unique products. Through the two business areas, Drug Development and Chromatography, the company strives towards increasing the accessibility of innovative treatments and medicines in healthcare, for the benefit of patients around the world.

Lindahl’s team consisted of Mårten Steen, Erika Svensson, Helena Lindbäck and Michaela Larsson.

 

Related

  • 3/29/2022 4:30:15 PM Lindahl acted as legal advisor to Nanologica AB (publ) in connection with its listing on Nasdaq Stockholm
  • 4/17/2020 2:51:30 PM Lindahl assists Nanologica in preferential rights issue
  • 5/26/2020 12:41:14 PM Lindahl legal adviser to Nanologica in its private placement of shares providing the company with proceeds of SEK 57.1 million

Contact

  • Mårten Steen

    Uppsala

    marten.steen@lindahl.se +46 707 715 210
  • Erika Svensson

    Uppsala

    erika.svensson@lindahl.se +46 704 215 839
  • Helena Lindbäck

    Uppsala

    helena.lindback@lindahl.se +46 704 222 847
  • Michaela Larsson

    Uppsala

    michaela.larsson@lindahl.se +46 701 494 064
Pages
  • Start
  • About us
  • Areas
  • Our people
  • Latest news
  • Privacy
Our offices
  • Stockholm reception.stockholm@lindahl.se +46 8 527 70 800
  • Göteborg reception.goteborg@lindahl.se +46 31 799 10 00
  • Malmö reception.malmo@lindahl.se +46 40 664 66 50
  • Uppsala reception.uppsala@lindahl.se +46 18 16 18 50
  • Örebro reception.orebro@lindahl.se +46 19 20 89 00
  • Helsingborg reception.helsingborg@lindahl.se +46 42 17 53 00
Social media
  • Connect with us on social networks: Instagram, Linkedin, Youtube, Facebook,

Disclaimer

The material and information on this site is intended for general informational purposes only and does not constitute legal advice on any specific matter. Please note that all images on Lindahl's website, www.lindahl.se, are subject to intellectual property protection and downloading, publication, copying and/or other use of the images requires the written consent of the rights holder. You'll find Advokatfirman Lindahl KB's general terms and conditions here.

Some cookies are essential, others help us improve your experience by providing insights into how the site is used. For more information, please visit our Cookie Policy.

Essential Cookies

These cookies are necessary for the functionality of the site and cannot be disabled.

Analytics Cookies>

We use Analytics cookies to collect information that gives us insight into how our website is being used. We anonymize IP addresses in Google Analytics. By clicking on Decline we won't save theese cookies.

Decline
We use cookies to get insights on how our site is used and give our visitors the best possible experience